drugset
drugset / Trial / NCT01172522

Topical Treatment of Under Eye Dark Circles and Swelling

NCT01172522 ↗

Phase 2 Completed 30 enrolled The Connecticut Sinus Center, PC TKL Research, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study examines topical treatment of under eye circles and swelling.

Timeline

Start
2010-09
Primary completion
2010-12
Completion
2011-01

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Fexofenadine vs Placebo; p =1; Other 0; Chi-squared NCT01172522 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Fexofenadine Unknown 1 % Topical

Indications

No indication recorded.